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httpThe prognosis of patients on hemodialysis with foot
lesions
YukiOrimoto,MD,TakashiOhta,MD,Hiroyuki Ishibashi,MD, Ikuo Sugimoto,MD,Hirohide Iwata,MD,
Tetsuya Yamada, MD, Masao Tadakoshi, MD, and Noriyuki Hida, MD, Nagakute, Japan
Objective: Many studies have shown the high prevalence and incidence of peripheral arterial disease and the marked
morbidity and mortality associated with peripheral arterial disease in hemodialysis patients. The purpose of this retro-
spective study was to clarify the probability of survival and limb salvage in patients with foot lesions and how to manage
these patients.
Methods: Data were collected in a retrospectively maintained database for 319 lower limbs with foot lesions in 234
hemodialysis patients treated in a university hospital between 1980 and 2011. Variances inﬂuencing survival and limb
salvage were compared using log-rank tests and Cox regression analysis. These variables were examined using Kaplan-
Meier analysis. Signiﬁcant factors in bivariate analysis were included in a logistic regression model to determine
independent predictors and the probability of failure.
Results: The 234 patients (72% men) were a mean age of 65.4 years on admission, and 84% had diabetes. The mean
duration of hemodialysis was 6.8 years. During the follow-up period, 171 patients (73%) died. The 1-, 3-, 5-, and 7-year
survival rates were 65.2%, 35.5%, 23.4%, and 12.8%, respectively. According to Cox multivariate models, age at admission
and ischemic changes on an electrocardiogram independently increased the risk of death (hazard ratios, 1.02 and 1.48,
respectively). Conversely, hyperlipidemia independently decreased the risk of death (hazard ratio, 0.56). Critical limb
ischemia was present in 247 limbs (77%). Arterial reconstruction was done in 88 limbs (28%), and 119 limbs (37%)
required major amputation. The overall 1-, 3-, 5- and 7-year limb salvage rates were 68.9%, 57.2%, 53.8%, and 51.7 %,
respectively. According to Cox multivariate models, patent arterial reconstruction and albumin independently decreased
the risk of major amputation (hazard ratios, 0.265 and 0.392, respectively).
Conclusions: Hemodialysis patients with foot lesions have a poor prognosis, with high rates of mortality and amputation.
Prompt assessments of the severity of systemic conditions, such as cardiac ischemia, and focal wound conditions, such as
ischemia and infection, are necessary to treat hemodialysis patients with foot lesions. (J Vasc Surg 2013;58:1291-9.)With the rapid aging of society, diabetic mellitus
patients are markedly increasing in Japan. The number of
patients who require dialysis for end-stage renal failure
has also been increasing. According to the Japanese Society
for Dialysis Therapy Annual Report, the total dialysis pop-
ulation was 298,252 at the end of 2010. The mean age of
new dialysis patients in 2010 was 67.8 years, which was
5.1 years older than that in 1999. The percentage of new
dialysis patients resulting from diabetic nephropathy was
43.6% in 2010, which was 7.3% higher than that in
1996.1 Peripheral arterial disease (PAD) is common among
patients on dialysis. An international survey reported that
the prevalence of PAD was 25.3%, with wide variations
among 12 countries, from 12% in Japan to 38% in
Belgium.2 The annual incidence of ischemic gangrene of
the extremities due to arteriosclerosis obliterans wastheDivision of Vascular Surgery, Department of Surgery, AichiMedical
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diabetic patients without renal disease and was 7.1/1000
in nondiabetic hemodialysis patients and 41.4/1,000 in
diabetic hemodialysis patients.3
These studies stressed the high prevalence and inci-
dence of PAD and marked morbidity and mortality
associated with PAD in hemodialysis patients. The purpose
of this retrospective study was to clarify the probability of
survival and limb salvage in patients with foot lesions and
how to manage these patients.METHODS
Patients. This study retrospectively enrolled 319 lower
limbs with ulcers or gangrene in 234 hemodialysis patients
who were consecutively treated in the Department of
Vascular Surgery of Aichi Medical University between
January 1980 and December 2011.
Laboratory data, the cardiothoracic ratio (CTR) on
chest radiographs, and the electrocardiogram (ECG)
were examined in all patients. A history of coronary artery
disease was deﬁned as a previous intervention of coronary
artery bypass grafting or percutaneous coronary interven-
tion or as deﬁnite myocardial infarction on ECG. Cerebro-
vascular disease (CVD) was deﬁned as a history of cerebral
bleeding or cerebral infarction.
All wounds were retrospectively classiﬁed using the
University of Texas Diabetic Wound Classiﬁcation, which1291
Table I. The University of Texas Diabetic Wound
Classiﬁcation
Stage
A B C D
No infection
or ischemia
Infection Ischemia Infection and
ischemia
Grade
0 I II III
Completely
epithelialized
Superﬁcial
wound
Wound penetrates
to tendon or
capsule
Wound penetrates
to bone or joint
Table II. Clinical characteristics of patients and limbs
Variablea
Patients
(n ¼ 234)
Limbs
(n ¼ 319)
Male 169 (72) 226 (71)
Age, years 65.4 6 0.7 65.9 6 0.6
Age on hemodialysis 59.1 6 0.8 59.3 6 0.7
Duration of HD, years 6.8 6 0.4 6.6 6 0.3
Mean follow-up, years 2.2 6 0.2 2.1 6 0.01
Cause of hemodialysis
Diabetic nephropathy 196 (84) 272 (85)
Glomerulonephritis 28 (12) 32 (10)
Polycystic kidney 4 (2) 5 (2)
Nephrosclerosis 3 (1) 3 (0.9)
Amyloidosis 2 (1) 3 (0.9)
Lupus nephritis 1 (0.4) 2 (0.6)
Nephrectomy 1 (0.4) 1 (0.3)
Risk factor
History of smoking habit 98 (42) 134 (42)
Hypertension 164 (70) 227 (71)
Hyperlipidemia 41 (18) 57 (18)
Diabetes mellitus 196 (84) 272 (85)
Type 1 16 (8) 21 (7)
Type 2 180 (92) 251 (93)
Duration, years 21.4 6 0.6 21.7 6 0.5
History of
CAD (CABG and/or PCI) 81 (35) 119 (37)
Heart failure 43 (18) 58 (18)
CVD 37 (16) 51 (16)
Malignancy 16 (7) 24 (8)
Examination
CTR >50% 98 (42) 132 (41)
Ischemic change on ECG 137 (59) 194 (61)
CLI 177 (77) 247 (77)
Affected limbs
One 149 (64) .
Two 85 (36) .
Treatments
Arterial reconstruction 74 (32) 88 (28)
Major amputation 97 (41) 119 (37)
CABG, Coronary artery bypass grafting; CAD, coronary artery disease; CLI,
critical limb ischemia; CTR, cardiothoracic ratio; CVD, cerebrovascular
disease; ECG, electrocardiogram; PCI, percutaneous coronary intervention.
aCategoric data are shown as number (%) and continuous data as mean 6
standard error.
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stages (from A to D), based on infection or ischemia, or
both (Table I). This study excluded wounds with grade
0 (epithelized wound) or stage A (no infection or
ischemia).4
Diagnostic evaluations. Noninvasive diagnostic eval-
uations are necessary to assess the healing potential of stage
5 and stage 6 feet in the Rutherford classiﬁcation.5 Our
previous study suggested that skin perfusion pressure (SPP)
>40 mmHg, ankle blood pressure >80 mmHg, toe blood
pressure >30 mm Hg, and transcutaneous oxygen pressure
>30 mm Hg were critical values for wound healing.6 In
this study, limbs that did not fulﬁll any of these values and
limbs in which vascular laboratory examinations could not
be performed due to massive tissue loss because of
advanced ischemia were included in the critical limb
ischemia (CLI) group.
Aggressive risk factor interventions, such as smoking
cessation, glycemic control, blood pressure control, and
lipid control, were performed soon after admission. Pain
control was performed using oral analgesics (nonsteroidal
anti-inﬂammatory drugs), and a sciatic nerve block above
the popliteal space using an ultrasound-guided puncture
method from 2006. Ropivacaine hydrochloride (0.20%-
0.25%) was continuously injected using an infusion
pump. A proton pump inhibitor was routinely administered
orally to prevent gastric ulcers being induced by drugs
(nonsteroidal anti-inﬂammatory drugs and antiplatelet
agents). The antibiotic regimen was changed according
to the results of bacterial cultures examined every week.
Except for severely infected limbs, bypass surgery was
indicated if a favorable general condition, correctable
ischemia, and available autogenous veins were present. Pol-
ytetraﬂuoroethylene grafts were used for revascularization
of the region up to the below-knee popliteal artery. Endo-
vascular arterial treatment (EVT) was performed in selected
patients with iliac lesions or in patients with infrainguinal
lesions without suitable autogenous veins. Stents were
only placed in iliac lesions because placement in infraingui-
nal lesions has yet to be covered by insurance in Japan.Negative-pressure wound therapy has been used for
severely infected wounds since 2005. Major amputation
was indicated for limbs with progression of infection or
tissue necrosis, or both, above the ankle joint.
Follow-up data were derived from medical records
and questionnaires. All treatments for ischemic limbs, and
the presence or absence of limb amputation in patients
who were still alive, were surveyed by direct interview,
written reports, or telephone. Replies for deceased patients
were obtained from the patients’ families by written
reports or telephone. Graft patency was examined using
duplex Doppler scanning, conventional arteriography, or
three-dimensional computed tomography. When direct
examination was impossible, graft patency was recorded
as unclear.
In this study, we analyzed several factors separately
inﬂuencing outcomes to demonstrate the problems associ-
ated with treating hemodialysis patients with foot lesions.
Table III. Comparison of clinical characteristics of
patients by date of admission (before and after 2005)
Variablea
Date of admission
P
1980-2004
(n ¼ 120)
2005-2011
(n ¼ 114)
Male 86 (72) 83 (73) .846b
Age, years 63.6 6 0.8 67.3 6 1.0 .003c
Age on hemodialysis, years 58.0 6 1.0 60.3 6 1.2 .148c
Duration of hemodialysis,
years
6.0 6 0.5 7.6 6 0.6 .147d
Mean follow-up, years 2.4 6 0.2 2.0 6 0.2 .833d
Risk factor
History of smoking habit 43 (36) 55 (48) .054b
Hypertension 90 (75) 74 (65) .112b
Hyperlipidemia 17 (14) 24 (21) .175b
Diabetes mellitus 105 (88) 91 (80) .112b
Type 1 7 (7) 9 (10)
Type 2 98 (93) 82 (90) .411b
Duration, years 20.7 6 0.8 22.6 6 0.9 .052d
History of
CAD (CABG and/or PCI) 35 (29) 46 (40) .072b
Heart failure 23 (19) 20 (18) .749b
CVD 11 (9) 26 (23) .004b
Malignancy 9 (8) 7 (6) .680b
Examination
CTR >50% 55 (46) 43 (38) .189b
Ischemic change on ECG 76 (63) 61 (54) .145b
CLI 84 (70) 93 (82) .039b
Treatments
Arterial reconstruction 30 (25) 44 (39) .025b
Major amputation 61 (51) 36 (32) .003b
Death 113 (94) 58 (51) <.001b
CABG, Coronary artery bypass grafting; CAD, coronary artery disease; CLI,
critical limb ischemia; CTR, cardiothoracic ratio; CVD, cerebrovascular
disease; ECG, electrocardiogram; PCI, percutaneous coronary intervention.
aCategoric data are shown as number (%) and continuous data as mean 6
standard error.
bc2 test.
cUnpaired t-test.
dMann-Whitney U test.
Fig 1. Overall survival rates in 234 hemodialysis patients with foot
lesions. The dotted lines indicate the standard error (SE).
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Stata 7.0 software (StataCorp LP, College Station, Tex).
Kaplan-Meier analysis was used to estimate survival and
limb salvage between groups. Variances inﬂuencing survival
and limb salvage were compared using log-rank tests.
Patients were grouped according to the following variables
to compare survival and limb salvage: sex, smoking, habits,
hypertension, hyperlipidemia, diabetes, diabetes type,
history of cardiovascular disease, heart failure, CVD and
malignancy, diseased limb, CLI, CTR, ischemic changes on
ECG, arterial reconstruction, and major amputation.
We conducted univariate analysis of variances inﬂu-
encing survival and limb salvage using Cox regression anal-
ysis as the ﬁrst step. We applied the “power law forces
method” for the selection of variances, and the Wald test
was used to test coefﬁcients. We conducted multivariate
analysis of variances inﬂuencing survival and limb salvage
using Cox regression analysis as the second step, the selec-
tion of variances involved the “step-up procedure stepwise(likelihood ratio),” and the Wald test was used to test coef-
ﬁcients. A P value < .05 was deﬁned as signiﬁcant.
RESULTS
The clinical characteristics of 234 patients (72% male)
and 319 limbs are summarized in Table II. Patients were
a mean 6 standard error (SE) age of 65 6 1 years, 84%
had diabetes mellitus, 42% had a history of smoking, 70%
were hypertensive, and 18% had a prior diagnosis of
hyperlipidemia. Fifty-ﬁve percent had advanced coronary
artery disease, deﬁned by previous coronary artery bypass
grafting or previous percutaneous coronary intervention
in 35%. Sixteen percent of patients had a history of symp-
tomatic CVD.
During the follow-up period, 171 patients (73%) died.
The primary cause of death was cardiovascular events
(n ¼ 105): heart failure (n ¼ 70), myocardial infarction
(n ¼ 23), and fatal arrhythmia (n ¼ 11). Other causes
of death were cerebrovascular events (n ¼ 21), sepsis
(n ¼ 17), visceral events (n ¼ 14), pneumonia (n ¼ 6),
malignancy (n ¼ 3), operative death in other hospitals
(n ¼ 2), and unknown (n ¼ 3). Two of 74 patients with
arterial reconstruction died #30 days of the operation of
fatal arrhythmia and bowel necrosis.
The backgrounds of the 234 patients in time sequence
were studied. There were 120 patients (51.3%) in the
period up to 2004 and 114 (48.7%) in the period since
2005. A comparison of the groups from these two periods
showed signiﬁcantly higher values for the latter of the age
at admission (P ¼ .003) and of the proportions of patients
with histories of CVD (P ¼ .004), of patients with CLI
(P ¼ .039), and of patients who had undergone arterial
reconstruction (P ¼ .025). Although no difference was
found in the duration of follow-up between the two
groups, the rates of mortality (P < .001) and of major
amputation (P ¼ .003) were signiﬁcantly lower for the
latter group (Table III). Overall, 1-, 3-, 5-, and 7-year
survival rates were 65.2% 6 3.2%, 35.5% 6 3.3%,
23.4% 6 3.2%, and 12.8% 6 3.1%, respectively. The
Table IV. Estimation of survival between groups according to the Kaplan-Meier methods
Variances Group Patients, No. Died, No. Mean SE 95% CI Pa
Sex F 65 48 2.803 0.379 2.060-3.546 .950
M 169 123 3.432 0.392 2.664-4.199
Smoking habits  136 106 2.779 0.278 2.234-3.324 .211
þ 98 65 3.928 0.667 2.620-5.236
Hypertension  69 47 4.047 0.697 2.680-5.414 .427
þ 164 124 2.778 0.239 2.310-3.247
Hyperlipidemia  192 146 3.112 0.348 2.430-3.794 .005
þ 41 25 3.866 0.417 3.048-4.684
Diabetes mellitus  38 24 5.283 1.083 3.161-7.404 .726
þ 196 147 2.933 0.237 2.468-3.398
Type of diabetes mellitus 1 16 11 3.281 0.994 1.334-5.229 .788
2 180 136 2.878 0.236 2.415-3.342
CAD (CABG and/or PCI)  153 112 3.070 0.277 2.526-3.614 .516
þ 81 59 3.326 0.584 2.181-4.471
Heart failure  191 137 3.619 0.384 2.865-4.372 .174
þ 43 34 2.230 0.370 1.504-2.955
CVD  197 146 3.387 0.351 2.699-4.076 .951
þ 37 25 3.046 0.557 1.955-4.137
Malignancy  218 157 3.525 0.357 2.826-4.225 .186
þ 16 14 2.001 0.553 0.916-3.085
Diseased limb 1 148 101 2.833 0.320 2.205-3.460 .204
2 85 69 3.706 0.485 2.756-4.656
CTR  135 95 3.455 0.327 2.815-4.095 .019
þ 98 75 2.682 0.432 1.834-3.529
Ischemic change on ECG  97 63 4.378 0.610 3.183-5.574 .017
þ 137 108 2.525 0.260 2.015-3.034
CLI  57 38 4.334 0.700 2.962-5.706 .054
þ 177 133 2.794 0.263 2.278-3.310
Arterial reconstruction  160 124 2.126 0.191 2.026-2.226 .085
þ 74 46 2.268 0.178 2.068-2.468
Major amputation  137 88 4.306 0.516 3.294-5.318 <.001
þ 97 83 2.005 0.247 1.522-2.489
CABG, Coronary artery bypass grafting; CAD, coronary artery disease; CI, conﬁdence interval; CLI, critical limb ischemia; CTR, cardiothoracic ratio; CVD,
cerebrovascular disease; F, female; M, male; PCI, percutaneous coronary intervention; SE, standard error.
aP values were calculated by log-rank test.
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conﬁdence interval, 2.7-4.0 years; Fig 1).
The estimation of survival between two groups was
assessed according to the Kaplan-Meier method
(Table IV). Hyperlipidemia (P ¼ .005), CTR >50%
(P ¼ .019), ischemic changes on ECG (P ¼ .017), and
major amputation (P < .001) signiﬁcantly inﬂuenced
survival. Survival was not inﬂuenced by CLI (P ¼ .054)
or arterial reconstruction (P ¼ .085).
Factors associated with survival according to Cox
univariate models are shown in Fig 2, A. Age at admission,
age on commencing hemodialysis, CTR >50%, ischemic
changes on ECG, and major amputation independently
increased the risk of death (hazard ratios [HRs], 1.04,
1.02, 1.44, 1.46, and 1.32, respectively). However, hyper-
lipidemia and a higher level of hemoglobin and albumin
independently decreased the risk of death (HRs, 0.54,
0.91, and 0.680, respectively). Factors associated with
survival according to Cox multivariate models are shown
in Fig 2, B. Age at admission and ischemic changes on
ECG independently increased the risk of death (HRs,
1.02 and 1.48, respectively). Conversely, hyperlipidemia
independently decreased the risk of death (HR, 0.56).CLI was documented in 247 limbs (77%). Of 88 limbs
(28%) that underwent arterial reconstruction, 67 arterial
reconstructions were patent at the end of the follow-up
period, and 20 limbs underwent major amputation. Of
67 limbs with infrapopliteal arterial reconstruction, 14
underwent major amputation, and three of these limbs
were amputated despite patent grafts because of uncon-
trolled infection (Table V). Major amputation was per-
formed in 99 of 231 nonrevascularized limbs (43%)
because of the presence of necrosis or infection, or both,
in a broad area and the absence of anastomosis-applicable
runoff vessels and useful autogenous veins.
The fates of limbs according to the Texas University
Diabetic Wound Classiﬁcation are summarized in
Table VI. Major amputation was performed mainly on
stage C/grade III and stage D/grade III limbs. Of
119 limbs, 101 (85%) were in stage C/grade III (n ¼
26) or stage D/grade III (n ¼ 75). Three limbs that
underwent major amputation despite patent femorotibial
bypass were in stage D/grade III. During the follow-up
period, 119 limbs (37%) underwent major amputation
(33 above the knee; 86 below the knee). Of these, 57
were amputated #30 days of hospitalization. Overall, 1-,
Table V. Arterial reconstructions and fates of the limbs
Variable
Limbs,
No.
Patent,
No.
Major
amputation,
No.
Bypass and hybrid reconstruction
Aorto/iliac-femoral 5 4 1
Axillofemoral 2 1 0
Femoral-femoral 3 2 1
Femoraleabove-knee popliteal 7 5 1
Femoralebelow-knee popliteal 18 (1a) 14 3
Femoral/popliteal-tibial/
paramalleoral
45 (2a) 37 11 (3b)
Endovascular treatment
Iliac 1 0 0
Superﬁcial femoral 3 2 1
Superﬁcial femoral and tibial 4 2 2
Total 88 67 20
aAdded endovascular arterial treatment of the iliac artery.
bMajor amputation despite patent graft.
A
B
Fig 2. Mortality risk according to Cox (A) univariate models and
(B) multivariate models. Hazard ratios (HRs) and 95% conﬁdence
intervals (CIs) are shown for all factors that reached signiﬁcance (P<
.05). Alb, Albumin; CTR, cardiothoracic ratio; ECG, electrocar-
diogram;Hb, hemoglobin;HD, hemodialysis;HL, hyperlipidemia.
Table VI. Fate of the limbs according to the Texas
University Diabetic Wound Classiﬁcation
Stage/
Grade
Limbs,
No. (%)
CLI,
No. (%)
AR,
No. (%)
Patent,
No. (%)
Major
amputation,
No. (%)
B/I 4 (1.3) 0 0 0 0
B/II 2 (0.6) 0 0 0 0
B/III 3 (0.9) 0 0 0 0
C/I 16 (5.0) 12 (4.9) 5 (5.7) 2 (3.0) 2 (1.7)
C/II 27 (8.5) 22 (8.9) 11 (12.5) 9 (13.4) 6 (5.0)
C/III 70 (21.9) 59 (23.9) 18 (20.5) 16 (23.9) 26 (21.8)
D/I 17 (5.3) 0 (4.0) 7 (8.0) 6 (9.0) 2 (1.7)
D/II 41 (12.9) 28 (11.3) 9 (10.2) 8 (11.9) 8 (6.7)
D/III 139 (43.6) 116 (47.0) 38 (43.2) 26 (38.8) 75 (63.0)
Total 319 247 88 67 119
AR, Arterial reconstruction; CLI, critical limb ischemia.
Fig 3. Overall limb salvage rates of 319 limbs with foot lesions.
The dotted lines indicate the standard error (SE).
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57.2% 6 3.3%, 53.8% 6 3.7%, and 51.7% 6 4.1%, respec-
tively. The mean 6 SE of limb salvage was 5.7 6 0.4 years
(95% conﬁdence interval, 5.0-8.5 years; Fig 3).
The estimation of limb salvage between groups was
assessed according to the Kaplan-Meier method. A CTR
>50%, CLI, arterial reconstruction, infrapopliteal arterial
reconstruction, and patent arterial reconstruction signiﬁ-
cantly affected limb salvage (Table VII).Factors associated with limb salvage according to Cox
univariate models are shown in Fig 4, A. An older age at
admission, a higher CRP, CTR >50%, and CLI indepen-
dently increased the risk of major amputation (HRs,
1.02, 1.03, and 3.58, respectively). However, a higher level
of hemoglobin and albumin, arterial reconstruction, and
patent arterial reconstruction independently decreased
the risk of major amputation (HRs, 0.83, 0.41, 0.43,
and 0.28, respectively). Factors associated with limb
salvage according to Cox multivariate models are shown
in Fig 4, B. Patent arterial reconstruction and albumin
independently decreased the risk of death (HRs, 0.265
and 0.392, respectively).DISCUSSION
PAD is one of the important determinants of overall
survival in patients on hemodialysis. The survival rates of
Table VII. Estimation of limb salvage between groups according to the Kaplan-Meier methods
Variances Group
Limb,
No.
Major
amputation, No. Mean SE 95% CI Pa
Gender F 93 39 4.553 0.484 3.604-5.501 .180
M 226 80 5.934 0.442 5.069-6.800
History of smoking habits  185 68 5.136 0.365 4.420-5.825 .756
þ 134 51 5.734 0.556 4.645-6.823
Hypertension  91 32 6.479 0.592 5.320-7.639 .927
þ 227 86 4.816 0.355 4.121-5.511
Hyperlipidemia  262 101 5.510 0.414 4.697-6.322 .169
þ 57 18 4.431 0.420 3.607-5.255
Diabetes mellitus  47 13 6.921 0.879 5.197-8.645 .146
þ 272 106 5.157 0.356 4.459-5.855
Type of diabetes mellitus 1 21 9 4.909 0.954 3.038-6.779 .789
2 251 97 5.150 0.381 4.403-5.897
CAD (CABG and or PCI)  200 77 5.313 0.387 4.554-6.073 .686
þ 119 40 5.983 0.606 4.794-7.171
Heart failure  261 92 6.141 0.398 5.360-6.922 .088
þ 58 27 2.646 0.346 1.967-3.325
CVD  268 100 5.786 0.399 5.003-6.569 .403
þ 51 19 3.423 0.458 2.525-4.322
Malignancy  295 108 5.855 0.388 5.095-6.615 .155
þ 24 11 1.810 0.356 1.111-2.508
CTR>50%  187 57 6.192 0.396 5.415-6.969 .001
þ 132 62 4.383 0.625 3.158-5.608
Ischemic change on ECG  125 46 5.953 0.545 4.884-1.021 .356
þ 194 73 4.569 0.325 3.932-5.207
CLI  72 11 8.962 0.485 8.012-9.912 <.001
þ 247 108 4.231 0.336 3.571-4.890
AR  231 99 5.133 0.416 4.317-5.949 <.001
þ 88 20 4.656 0.304 4.060-5.253
Infrapopliteal AR  252 105 5.247 0.405 4.452-6.041 .001
þ 67 14 4.621 0.316 4.002-5.240
Patent AR  21 10 3.369 0.633 2.127-4.610 .003
þ 67 9 5.187 0.303 4.593-5.781
AR, Arterial reconstruction; CABG, coronary artery bypass grafting; CAD, coronary artery disease; CI, conﬁdence interval; CLI, critical limb ischemia; CTR,
cardiothoracic ratio; CVD, cerebrovascular disease; HF, heart failure; PCI, percutaneous coronary intervention; SE, standard error.
aP values were calculated by log-rank test.
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year and 73% at 5 years, and rates in hemodialysis patients
with PAD were 90% at 1 year and 59% at 5 years.2 In
contrast, the survival rates of hemodialysis patients with
foot lesions in this series were very poor, at 65% at 1
year, 36% at 3 years, and 23% at 5 years, with a mean
survival of only 1.8 years. A comparison of the 5-year
survival rates of hemodialysis patients in this study and
patients with various malignant diseases in Japan is shown
in Fig 5.7 The 5-year survival rate of hemodialysis patients
with foot lesions was very poor, and only those with
pancreatic cancer had a lower survival rate.
Our results of multivariate analysis showed that
mortality in hemodialysis patients with foot lesions
depended on the age at admission, hyperlipidemia, and
ischemic changes on ECG. The HR at the age on admission
was 1.02, very close to 1. The HR of age was calculated for
age by 1 year. Thus, although the ratio appeared to be low,
signiﬁcance was detected.
Serum cholesterol levels have been strongly associated
with serum albumin levels and serve as a good index of
nutritional condition.8 Hypolipidemia is often observedin dialysis patients. The cause has not yet been clariﬁed
but may be due to malnutrition and chronic inﬂammation.
The total cholesterol level was#160 mg/dL in 249 of 823
(30.3%) maintenance dialysis patients, whereas this level
was >240 mg/dL in only 132 (13.9).9 In our study,
hyperlipidemia was noted only in 41 patients (18%).
Hyperlipidemia was also demonstrated to decrease the
mortality rate of dialysis patients, showing a “paradoxic
relationship.”8,10,11 Hyperlipidemia was also a factor that
decreased morality (HR, 0.56) in our study. Hyperlipid-
emia is a risk factor for cardiovascular events, similar to
that in the general population, and mortality increases
when serum cholesterol levels are too low and too high.9
Recently, the relationship between cardiovascular
disease and malnutrition-inﬂammation-atherosclerosis
syndrome in patients with end-stage renal failure was
proposed.12 Although the pathogenesis is not yet fully
understood, malnutrition and systemic vascular disorders
are common in dialysis patients and are closely related to
morbidity and mortality. Locatelli et al13 suggested that
there are at least two fundamentally different types ofmalnu-
trition in patients with chronic renal insufﬁciency. The ﬁrst
AB
Fig 4. Major amputation risk according to the Cox (A) univariate
models and (B)multivariate models. Hazard ratios (HRs) and 95%
conﬁdence intervals (CIs) are shown for all factors that reached
signiﬁcance (P < .05). Alb, Albumin; AR, arterial reconstruction;
CLI, critical limb ischemia; CRP, C-reactive protein; CTR,
cardiothoracic ratio; Hb, hemoglobin.
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intake. In these patients, the decrease in serum albumin
may be small and malnutrition may be reversed with
adequate nutritional and dialysis support. In contrast, the
second type of malnutrition is associated with inﬂammation.
This type is generally much more difﬁcult to reverse with
nutritional support and dialysis therapy, unless the under-
lying comorbid conditions and chronic inﬂammatory
response can be adequately treated.
Many patients with foot lesions in this study exhibited the
second type of malnutrition. Therefore, adequate nutritional
support involving protein and energy intake or supplements
may be not indicated. Several nutritional scores, such as
subjective global assessment,14 malnutrition-inﬂammation
score,15,16 and the geriatric nutritional risk index17 may
be useful to predict the survival of dialysis patients with
foot lesions.
Some authors have suggested that a low ankle-brachial
index was a powerful and independent predictor ofmortality
in hemodialysis patients.18,19 However, the ankle-brachial
index could not predict mortality because it could only be
measured in 107 hemodialysis patients with foot lesions
(46%) without severely calciﬁed tibial arteries or advanced
ischemia, or both.
Several reports have described the survival of dialysis
patients with PAD treated with bypass surgery. The 2-year
survival rates were 23% to 52%.20-24 In our study, 74 patients
(32%) underwent arterial reconstruction. Mortality #30
days after revascularization was low (2 of 74 [3%]). Overall,
1-, 3-, and 5-year survival rates were, respectively, 81%6 5%,44% 6 6%, and 20% 6 6% in patients with arterial recon-
struction and 61%6 4%, 34%6 4%, and 23%6 4% in those
without arterial reconstruction. Arterial reconstruction did
not lead to a better survival than in patients without recon-
struction (P¼ .085). However, there may be a bias because
the basic background of both groups of patients was
different. The arterial reconstruction group, with mainly
bypass surgery, included low-risk patients with a better
nutritional and functional status andwithout extensive tissue
loss. In contrast, the nonreconstruction group may have
included high-risk patients, in whom the risk was too high
for arterial reconstruction, and healthier patients who may
have needed arterial reconstruction due to less extensive
ischemic foot lesions. Survival analyses conﬁrmed poor
life expectancy for these patients but also indicated that
an acceptable quality of life may be achieved with arterial
reconstruction in appropriately selected patients.
Patients that we considered for treatment with revascu-
larization, ﬁrst, were those in whom infection from the foot
injury remained in the region up to the ankle joint level
and then those with SPP <40 mm Hg, ankle blood
pressure <80 mm Hg, toe blood pressure <30 mm Hg,
and transcutaneous oxygen pressure <30 mm Hg on
noninvasive diagnostic measurements judged as having
no capacity to heal ischemic wounds. When the systemic
condition was favorable, general anesthesia was applicable,
and when an autogenous vein was available, bypass surgery
was selected. Regarding EVT, a stent was placed only when
an iliac arterial lesion was observed because of the Japanese
insurance system. EVT was also selected and percutaneous
transluminal angioplasty was performed for lesions in the
inguinal region or lower when (1) no autogenous vein
was available for bypass surgery, and (2) bypass surgery
could not be performed using the popliteal artery as
a peripheral anastomosis site and an artiﬁcial (polytetra-
ﬂuoroethylene) blood vessel.
Survival was shown to be very poor in hemodialysis
patients with major amputation.25,26 In our series, major
limb amputations independently increased the risk of
death. Some studies have recommended the liberal use of
primary amputation because of the high level of mortality,
decreased wound healing, a prolonged hospital stay, and
poor rehabilitation after arterial reconstruction.27 Other
studies, however, have suggested that amputation may
carry more signiﬁcant morbidity and mortality risks in dial-
ysis patients than those of revascularization procedures.28
Considering that residual bias may still exist in the back-
grounds of the two groups of patients, careful selection
for revascularization or amputation is necessary.
The fate of the limb was relatively better than
mortality. Major amputations were performed #30 days
of hospitalization in 57 of 119 amputated limbs. According
to the Texas University Diabetic Wound Classiﬁcation,
major amputation was frequent in limbs with stage
C/grade III and stage D/grade III. Forty-one of these
limbs (72%) were stage C/grade III (n ¼ 14) or stage
D/grade III (n ¼ 27). The Texas University Diabetic
Wound Classiﬁcation was of use for planning the
Fig 5. Comparison of 5-year survival rates in hemodialysis (HD) patients with foot lesions and patients with cancer.
JOURNAL OF VASCULAR SURGERY
1298 Orimoto et al November 2013treatments but was less useful for deciding on major ampu-
tation because it does not clarify whether the extent of the
lesions or the severity of ischemia was the most important
factor for limb salvage. However, it was clear that most
patients had been introduced to us too late to save their
limbs. Early introduction, before advanced ischemic or
infectious lesions develop, may lead to better limb salvage
rates.
In our series, 88 limbs (28%) underwent arterial
reconstruction. Arterial reconstruction led to better limb
salvage than in limbs without reconstruction (P < .001).
However, there may be a bias because the basic back-
grounds of the two groups of limbs were different. The
arterial reconstruction group included selected limbs with
less extensive tissue loss or infection. In contrast, the
nonreconstruction group included limbs with excessive
tissue loss and uncontrollable infection, or both. In limbs
not treated with revascularization, the outcome was
a high rate of major amputation (99 of 231 limbs
[31%]). However, wounds healed without revasculariza-
tion in 132 limbs (41%), showing that revascularization
should be considered, including an evaluation of the
patient’s systemic condition.
This was a 31-year long-term study, during which the
diagnosis of CLI was clariﬁed using SPP, dialysis devices
were improved, new drugs appeared, such as antiplatelet
agents, antibiotics, and statins, and the diagnosis and treat-
ment of dialysis patients progressed, such as the develop-
ment of negative-pressure wound therapy. The study of
the backgrounds of the patients in time sequence for all
234 patients shows that the rates of mortality (P < .001)
and of major amputation (P ¼ .003) signiﬁcantly decreased
in patients hospitalized since 2005. Further, it may be
considered that the lower rate of major amputation,
despite the higher incidence of CLI, indicates that the
distal anastomotic part owes greatly to proactive arterial
reconstruction to the distal tibial or plantar artery.
We consider that this has been the longest large-scale
study in dialysis patients with foot lesions. The survivalrate of these patients was very low despite progresses in
dialysis devices, treatments, and drugs. We reported the
results of the long-term follow-up to emphasize that the
survival rate of these patients was very low and the major
amputation rate was high.
CONCLUSIONS
Hemodialysis patients with foot lesions have a poor
prognosis, with a high mortality rate and high amputation
rate. Although an acceptable level of limb salvage may be
achieved with arterial reconstruction only, it is important
to know how to identify candidates with an acceptable
life expectancy and those who may beneﬁt from arterial
reconstruction.
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